Table 2. Multiple linear regression of the relationship with CD4 change after 24 months of ART.
Subcategory | β-Coefficient (95% CI) | P-value | |
Incident TB after ART | No | 1 | |
Yes | −143.05 (−191.47–94.64) | <0.001 | |
Baseline CD4 count (cells/mm3, per 50 cells' rise) | −23.38 (−32.99–13.78) | <0.001 | |
Sex | Female | 1 | |
Male | −48.04 (−63.03–33.05) | <0.001 | |
Interaction term baseline CD4 and sex | 0.17 (0.05–0.29) | 0.004 | |
Age (years, per 10 years' rise) | −1.56 (−5.92–2.79) | 0.48 | |
Regimen | Non-AZT based | 1 | |
AZT-based | 4.56 (−1.64–10.76) | 0.15 |
ART, antiretroviral treatment; TB, tuberculosis; CI, confidence interval; AZT, zidovudine.